The present study was designed to examine the effect of Pseudomonas aeruginosa alkaline protease and elastase on human polymorphonuclear leukocyte chemiluminescence. Both a luminol-enhanced and a nonenhanced chemiluminescence system using opsonized zymosal were utilized. It was found that alkaline protease and elastase at concentrations of 25 ,ug/ml strongly inhibited luminol-enhanced myeloperoxidasemediated chemiluminescence, whereas inhibition of the nonenhanced chemiluminescence response was about 50%. In an attempt to determine the mechanism of inhibition of neutrophil chemiluminescence by these proteases, we examined the effect of various inhibitors of neutrophil oxidative metabolism on chemiluminescence, namely, superoxide dismutase, sodium azide, and catalase. It was shown that the pattern of inhibition of chemiluminescence by alkaline protease and elastase was similar to that of sodium azide, inhibitor of myeloperoxidase. The present study demonstrates that alkaline protease and elastase, extracellular products of P. aeruginosa, are capable of inhibiting myeloperoxidase-mediated chemiluminescence, one of the major antimicrobial systems of polymorphonuclear leukocytes. These findings provide further evidence for the role of P. aeruginosa exoproteases as virulence factors in the pathogenesis of infections caused by this microorganism.
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Pseudomonas aeruginosa has become an increasingly important clinical problem, particularly in compromised hosts such as cystic fibrosis and burn patients (6, 9) . P. aeruginosa produces several extracellular products, including alkaline protease (AP), elastase (Ela), and exotoxin A, which are involved in pathogenesis (3, 10, 11, 19, 23, 27) . Polymorphonuclear leukocytes (PMN) play an important role in host defence against P. aeruginosa (5, 12, 20, 28) . However, there are only few reports on the effect of P. aeruginosa products on human neutrophil function (22, 26) . Inhibition of phagocytic and killing activity of rabbit PMN by a P. aeruginosa extracellular product (the PMN inhibitor) has also been reported (17) .
The oxygen-dependent antimicrobial system is the most potent microbicidal property of PMN. The myeloperoxidase-hydrogen peroxide-halide system has been demonstrated to play the major role in the oxygen-dependent antimicrobial system of neutrophils (14) (15) (16) 24 (8, 21, 25) . It has been well documented that luminol-enhanced chemiluminescence is myeloperoxidase mediated, whereas nonenhanced zymosan-induced chemiluminescence is due to the superoxide anion as well as to myeloperoxidase (2, 7, 8) .
In our previous study the effect of P. aeruginosa AP and Ela on human PMN chemotaxis, oxygen consumption, glucose oxidation, and superoxide production has been reported (13) . This paper describes the mechanism of inhibition of neutrophil chemiluminescence by P. aeruginosa AP and Ela. * Corresponding author.
MATERIALS AND METHODS AP and Ela. AP and Ela were prepared from P. aeruginosa 1 and 9 as described earlier (18) . Both proteases were purified by ammonium sulfate precipitation, Sephadex G-100 gel filtration, and DEAE-sephacel chromatography. Purity of the enzymes was checked by sodium dodecyl sulfatepolyacrylamide gel electrophoresis. Both proteases revealed only one band each on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, at 57,000 daltons for AP and at 39,000 daltons for Ela. AP ws most active at or between pH 9 and 10 and cleaved casein and gelatin, whereas Ela had optimal activity at or between pH 8 and 9, and in addition to casein and gelatin, it also cleaved elastin. The specific activity as determined by the azocaseine assay was 0.438 PU/mg for AP and 0.610 PU/mg for Ela.
Neutrophils. Neutrophils were prepared from citrated peripheral blood obtained from healthy individuals by dextran sedimentation and sodium metrizoate-Ficoll (Lymphoprep; Nyegaard, Oslo, Norway) separation (4 (ii) Luminol-enhanced system. The luminol-enhanced assay was similar to that described above. Because of the sensitivity of the assay system, the PMN number was reduced to 5 x 104 cells per vial. The concentration of opsonized zymosan was the same, and the total volume of reaction mixture was 5.5 ml. Luminol (5-amino-2,3-dihydro-1,4-phtalazinedione), obtained from Sigma Chemical Co., St. Louis, Mo., was maintained as a stock solution of 10 mg/ml in NaGH (0.1 N) and diluted in Gey balanced salt solution immediately before use. The final concentration of luminol in the assay mixture was 5 x 10-8 M; the small amount of NaOH had no effect on chemiluminescence.
RESULTS
The peak chemiluminescence response of neutrophils stimulated with opsonized zymosan in both the luminolenhanced and the nonenhanced systems occurred between 20 and 30 min after the addition of cells to the reaction mixture. The summary of peak chemiluminescence response of neutrophils stimulated witth opsonized zymosan using both the nonenhanced and the luminol-enhanced systems is shown in Table 1 . The peak chemiluminescence response of zymosan-stimulated neutrophils in the presence of 25 ,g of AP or Ela per ml was 63 and 59% of control, respectively, in the nonenhanced system. In the luminol-enhanced system the peak chemiluminescence response in the presence of 25 ,ug of AP or Ela per ml was 17 and 26% of control, respectively. AP and Ela exhibited a stronger inhibitory effect on the chemiluminescence of neutrophils in the luminol-enhanced system as compared with the nonenhanced system (Fig. 1) . In an attempt to determine the mechanism of inhibition of neutrophil chemiluminescence by AP and Ela, we examined the effect of known concentrations of various inhibitors of neutrophil oxidative metabolism on chemiluminescence. PMN were preincubated with 50 ,ug of superoxide dismutase, inhibitor of superoxide anion, per ml; 1 mM sodium azide, inhibitor of myeloperoxidase; and 100 ,ug of catalase, inhibitor of hydrogen peroxide, per ml for 60 min at 37°C (Table 1 and Fig. 2) . It was found that the chemiluminescence response in the presence of superoxide dismutase was 44% of control in the nonenhanced system and more than 80% of control in the luminol-enhanced system. The response in the presence of sodium azide was about 50% of control in the nonenhanced system and less than 25% of control in the luminol-enhanced system. The response in the presence of catalase was similar to that of control in both the nonenhanced and the luminol-enhanced systems. Thus, it appears that AP and Ela show a mechanism of inhibition similar to that of sodium azide but different from that of superoxide dismutase.
When superoxide dismutase and AP or superoxide dismutase and Ela were both present in the reaction mixture in the nonenhanced system, the extent of inhibition was increased as compared with superoxide dismutase alone or AP and Ela alone (Fig. 3) . DISCUSSION In a recent report we presented evidence for the involvement of P. aeruginosa AP and Ela on inhibition of human PMN function (13) . It was demonstrated that both proteases were capable of inhibiting neutrophil chemotaxis and also interfering with the oxidative metabolism of these cells.
AP and Ela inhibited the luminol-enhanced chemiluminescence of neutrophils strongly and inhibited the nonenhanced chemiluminescence response by only about 50%. The reports of DeChatelet et al. (8), Bender and Van Epps (2), and Dahlgren and Stendahl (7) that luminol-enhanced chemiluminescence is primarily myeloperoxidase mediated supports our finding in the present study that AP and Ela may act on myeloperoxidase. Our findings on the bimodal nature of chemiluminescence and the role of myeloperoxidase in luminol-dependent chemiluminescence are in complete agreement with the previous reports (2, 7, 8) .
Further support of the inhibition of myeloperoxidasemediated chemiluminescence by AP and Ela is provided by the experiments in which AP and Ela were used in combination with superoxide dismutase in the nonenhanced chemiluminescence system. It was found that the inhibition of chemiluminescence was markedly increased by the addition of superoxide dismutase to AP or Ela as compared with each one alone. More direct evidence for the effect of AP and Ela Inhibition of myeloperoxidase-mediated chemiluminescence of human neutrophils by P. aeruginosa AP and Ela seems to be similar to that of sodium azide, inhibitor of myeloperoxidase. The mechanism of inhibition, however, is more likely due to a proteolytic inactivation of myeloperoxidase by AP and Ela. We are currently examining the effect of AP and Ela on function and proteolytic cleavage of purified neutrophil myeloperoxidase and on PMN-mediated bacterial killing.
The effect of the two proteases on various steps of the neutrophil oxidative metabolism may differ. In the present study both enzymes inhibited the chemiluminescence response of neutrophils. However, in our previous report it was shown that AP inhibited oxygen consumption with no effect on superoxide production, whereas Ela had no effect on oxygen consumption but an inhibitory effect on superoxide produced by neutrophils (13 
